Previous work suggested that the dependency of the prostate cancer cells on the FABP5-related pathway was gradually increased with a correspondingly reduced dependency on the AR-initiated pathway until the former became completely dominant [7]. This evidence concerns the gene FABP5 and prostate carcinoma.